Next report date
Report period
H1 2024
EPS estimate
—
Revenue estimate
—
−19.56 MEUR
1.44 MEUR
133.66 M
About VALERIO THERAPEUTICS
Sector
CEO
Shefali Agarwal
Headquarters
Paris
Website
Employees (FY)
32
Founded
1997
ISIN
FR0010095596
FIGI
BBG000HQ55Z8
Valerio Therapeutics SA is a is a clinical-stage biotechnology company, which engages in the development of drugs for the treatment of orphan diseases. The firm produces and develops orphan oncology products under the brand names Livatag, Validive, Beleodaq and AsiDNA. The company was founded by Jean Theron, Gilles Avenard, and Dominique Costantini on March 5, 1997 and is headquartered in Paris, France.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ALVIO is 0.1080 EUR — it has decreased by 3.05% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange VALERIO THERAPEUTICS stocks are traded under the ticker ALVIO.
VALERIO THERAPEUTICS is going to release the next earnings report on Jul 26, 2024. Keep track of upcoming events with our Earnings Calendar.
ALVIO stock is 7.41% volatile and has beta coefficient of 0.64. Check out the list of the most volatile stocks — is VALERIO THERAPEUTICS there?
Yes, you can track VALERIO THERAPEUTICS financials in yearly and quarterly reports right on TradingView.
ALVIO stock has fallen by 7.06% compared to the previous week, the month change is a 1.82% fall, over the last year VALERIO THERAPEUTICS has showed a 62.11% decrease.
Today VALERIO THERAPEUTICS has the market capitalization of 17.16 M, it has decreased by 1.69% over the last week.
No, ALVIO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ALVIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VALERIO THERAPEUTICS stock right from TradingView charts — choose your broker and connect to your account.
As of May 1, 2024, the company has 32.00 employees. See our rating of the largest employees — is VALERIO THERAPEUTICS on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VALERIO THERAPEUTICS technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VALERIO THERAPEUTICS stock shows the sell signal. See more of VALERIO THERAPEUTICS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on VALERIO THERAPEUTICS future price: according to them, ALVIO price has a max estimate of 1.20 EUR and a min estimate of 1.20 EUR. Read a more detailed VALERIO THERAPEUTICS forecast: see what analysts think of VALERIO THERAPEUTICS and suggest that you do with its stocks.